USPTO serial 88424864
PHARNEXT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 2, 2020
- Examiner
- TARASCIO, MAUREEN J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PHARNEXT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $2,125
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ISSY-LES-MOULINEAUX, FR
ISSY-LES-MOULINEAUX, FR
ISSY-LES-MOULINEAUX, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carlynn Ferguson Davis
Carlynn Ferguson Davis IPHORGAN LTD.195 NORTH ARLINGTON HEIGHTS ROADSUITE 125BUFFALO GROVE, IL 60089Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicine, namely, medicines for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical products for human use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical preparations for human or veterinary use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; biological preparations for medical purposes for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; diagnostic preparations for medical diagnosis purposes; chemical preparations for medical purposes, namely, for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; food supplements and nutritional supplements for medical purposes; dietetic foods and beverages adapted for medical and pharmaceutical purposes; homeopathic and phyto-therapeutic supplements; disinfectants for hygiene purposes for medicine; bath preparations for medical purposes; dietetic beverages adapted for medical purposes; chemical reagents for medical use, namely, biomarkers; products for personal hygiene for medical purposes, namely, medical soaps; plasters and gauze for dressings for medical purposes; medical dressings, except instruments | ACTIVE | — |
| 035 | Creation, compilation and management of databases and central data files in the field of pharmaceutical research and development, medicine, genetics and clinical trials; compilation of statistics in the field of health and medicine; collection and systematization of data in a central file in the field of pharmaceutical research and development, health and medicine; public relations in the field of health and medicine | ACTIVE | — |
| 041 | training services in the fields of health, pharmaceutical and medical research, pharmaceutical and medical development; publication of books and texts other than publicity texts in the pharmaceutical, medical and health fields; educational services, namely, arranging and conducting educational colloquiums, conferences, congresses, and seminars in the fields of pharmaceuticals, medical and health; teaching in the pharmaceutical, medical and health fields | ACTIVE | — |
| 042 | pharmaceutical products development; pharmaceutical research and development; conducting tests on pharmaceutical products; conducting clinical trials for pharmaceutical products for others; scientific research in the field of medicine; bioinformatics, chemical and biological analysis; scientific research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research and bioinformatics services in the field of chemical, biological and pharmaceutical products; software development and design in the field of pharmaceutical research, health and medicine; provision of scientific information relating to pharmaceutical products and medical and scientific research in the field of pharmaceuticals products and clinical trials; scientific research on chemical reagents for medical use, namely, biomarkers; pharmaceutical research services | ACTIVE | — |
| 044 | medical services; pharmaceutical advice services; pharmacy consultation; medical advisory and information services relating to pharmaceutical products; medical information services; provision of medical information; providing health information services on the treatment of diseases through an awareness program | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PHARNEXT
- Other trademarks owned by PHARNEXT
- Other trademarks owned by PHARNEXT
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PHARNEXT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 23, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 12, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 2, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 17, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 17, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 26, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 12, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 12, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 12, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 12, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 4, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 4, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 3, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 25, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2019 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| May 22, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 15, 2019 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 14, 2019 | NWAP | NEW APPLICATION ENTERED | — |